FDA delays decision on expansion of Gardasil (The Star-Ledger)
Since its approval by federal regulators two years ago, the Gardasil vaccine for cervical cancer has been one of Merck's most successful new products, generating more than $1 billion in sales annually.

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma ... (PR Newswire via Yahoo! Finance)
Eisai Corporation of North America announced today that the U.S. Food and Drug Administration has accepted for priority review a supplemental biologics license application for ONTAK .

U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) (Medical News Today)
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced that the U.S. Food and Drug Administration (FDA) has licensed Pentacel(R), Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine.